Watch Ticker

Kiniksa Pharmaceuticals, Ltd. Class A Common Stock

Go to Kiniksa Pharmaceuticals, Ltd. Class A Common Stock Website

$32.77

-0.18 (-0.55%)

Live

Previous Close

$33.07

Day Range

$32.82 - $33.98

Previous Day Range

$32.02 - $33.1

Market Cap

$2.4 billion USD

Day Vol.

1.3 million

Previous Day Vol.

848660

Currency

USD

Primary Exchange

Nasdaq

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

Kiniksa Pharmaceuticals announces plans for a Phase 2/3 clinical trial of its drug KPL-387 in recurrent pericarditis, with the trial expected to initiate in mid-2025 and Phase 2 data expected in the second half of 2026.

Related tickers: KNSA.

Read Full Article

N/A - Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Kiniksa Pharmaceuticals announced that country star Carly Pearce has joined their Life DisRPted campaign to raise awareness for recurrent pericarditis. The company also reported strong Q1 2025 financial results for their ARCALYST product, with net product revenue of $137.8 million and increased 2025 revenue guidance.

Related tickers: KNSA.

Read Full Article

Trending Tickers

Please sign in to view